Accès libre

Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway

Qing Su

Qing Su

Department of Orthopedic Oncology, Yantai Shan HospitalYantai, China
Recherchez cet auteur sur
Sciendo|Google Scholar
Su, Qing
, 
Baolin Xu

Baolin Xu

Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, China
Recherchez cet auteur sur
Sciendo|Google Scholar
Xu, Baolin
, 
Zhoubin Tian

Zhoubin Tian

Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityJinan, China
Recherchez cet auteur sur
Sciendo|Google Scholar
Tian, Zhoubin
 et 
Ziling Gong

Ziling Gong

Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalShanghai, China
Recherchez cet auteur sur
Sciendo|Google Scholar
Gong, Ziling
  
13 avr. 2022
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Publié en ligne: 13 avr. 2022
Pages: 389 - 402
Accepté: 14 déc. 2021
DOI: https://doi.org/10.2478/acph-2022-0026
Mots clés
© 2022 Qing Su et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Pharmacie, Pharmacie, autres
RSS Feed de la revue